Incyte Genomics, Inc. (INCY) Posts Narrower than Expected Q3 Loss
Tweet
Share
E-mailGet Alerts INCY Hot Sheet
Price: $108.53 +0.65%
Revenue Growth %: +29.4%
Financial Fact:
Diluted (in shares): 194.27M
Today's EPS Names:
PLCE, COE, JVA, More
Revenue Growth %: +29.4%
Financial Fact:
Diluted (in shares): 194.27M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Incyte Genomics, Inc. (NASDAQ: INCY) reported Q3 loss of ($0.42), $0.03 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $16.8 million versus the consensus estimate of $16.54 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Incyte (INCY) PT Raised to $140 at H.C. Wainwright
- Lennar Corp. (LEN) Misses Q2 EPS by 1c
- Stitch Fix (SFIX) Tops Q3 EPS by 4c, Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
